Skip to main
AHCO

AdaptHealth Corp (AHCO) Stock Forecast & Price Target

AdaptHealth Corp (AHCO) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 60%
Buy 40%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

AdaptHealth is well-positioned for future growth due to its focus on patient-centered, home-based healthcare solutions and its strong performance in its key segments, particularly Sleep Health. With a solid pipeline of potential capitated contracts and a track record of successful integration of acquisitions, the company is expected to continue expanding its market presence and achieving strong organic growth. Additionally, AdaptHealth's commitment to sustainability and diversity within its workforce further underscores its potential for long-term success and shareholder value.

Bears say

AdaptHealth is facing a negative outlook as there are several fundamental risks that could affect its future performance, including potential disruptions to operations, changes in the competitive landscape, and reimbursement pressure from government and third-party payors. Additionally, the company may face challenges related to potential regulatory issues or liabilities, as well as supply chain challenges such as the recent Philips recall. There is also a risk of slowing end-markets and internal control issues that could impact its financials.

AdaptHealth Corp (AHCO) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 60% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AdaptHealth Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AdaptHealth Corp (AHCO) Forecast

Analysts have given AdaptHealth Corp (AHCO) a Strong Buy based on their latest research and market trends.

According to 5 analysts, AdaptHealth Corp (AHCO) has a Strong Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AdaptHealth Corp (AHCO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.